Pharmaceuticals

Did You Receive an Email Requiring Registration to the State’s PMP? - 02/28/2024

TMA can confirm that an email sent Friday afternoon asking physicians to register for a PMP Aware account are indeed legitimate; however, there is no deadline to register.

Cannabidiol Takes a Big Step Toward Respectability - 01/25/2024

In September, the DEA issued an order listing all drugs approved by the U.S. Food and Drug Administration that contain cannabidiol but no more than 0.1 percent of the chief psychoactive agent in cannabis as Schedule V drugs — those with the least potential for abuse. So far, Epidiolex is the only medication that fits that description.

Medicare Part B Inflation Rebate Takes Effect, Lowering Copays - 06/27/2023

A new federal law requires drug companies to rebate Medicare if they raise certain drug prices higher than the rate of inflation, which has translated into lower copays for some Medicare patients.

Pharmacy Rule Opens Door to Improve Access to Low-Cost Medications - 02/06/2023

Given the high cost of medications, pharmacies should be sharing low-cost options with patients and allowing them to transfer their prescriptions as needed – without imposing additional administrative hassles on physician practices.

Counterfeit Medications Proliferate in Patient Care – and They’re Not Just Illicit Opioids - 01/31/2023

Counterfeit medications are a growing problem that can undermine medical treatment, and all physicians can help prevent their spread by asking patients simple questions.

Nationwide Adderall Shortage Expected to Last Through 2022 - 10/31/2022

The U.S. Food and Drug Administration (FDA) expects a nationwide shortage of Adderall and Adderall IR to extend through the end of the year, following manufacturing delays by the largest producer of Adderall in the country, Teva Pharmaceuticals LLC.

Are You Ready for Changes to Opioid Prescribing in Texas? - 10/14/2022

Beginning Sept. 1, all prescribers will be required to set up an account with the state’s prescription monitoring program, known as PMP Aware. The Texas State Board of Pharmacy will also begin issuing new official prescription forms that include advanced security features designed to help deter fraud.

Biden Executive Order Likely to Prompt Rulemaking on Noncompetes - 07/19/2021

Directly and indirectly, the Biden administration’s wide-ranging Executive Order on Promoting Competition in the American Economy features myriad implications for health care and physician practices. The executive order, issued earlier this month, takes aim at hospital and insurance market consolidation, noncompete agreements, lack of competition among drug manufacturers, and exorbitant costs of prescription drugs and hearing aids.

PMP Checks Won’t Be Necessary for In-Facility Medications, TMB Says - 02/21/2020

Thanks to Texas Medical Association advocacy, the Texas Medical Boardhas refocused its guidance on when physicians will be required to check the Texas Prescription Monitoring Program (PMP) before prescribing certain medications starting March 1.

Dispensing Drugs From a Medical Practice - 08/31/2017

Can a physician dispense prescription drugs (not samples) that the patient would self-administer at home? Can a physician purchase medications from a pharmacy or a drug company and sell them to his or her patients?

Drug Wastage Modifier Now Required - 01/13/2017

Coding change reminder: For Medicare claims, use modifier JW when you open a single-use package or vial of a drug but don’t administer the entire dose or quantity and discard what’s left. See examples and FAQs.

Board Pulls Plan for Pharmacists to Check Diagnoses - 02/13/2014

The Texas State Board of Pharmacy (TSBP) quickly killed a proposal that would have required pharmacists to contact the prescribing physician for each new patient with a prescription for a controlled substance. The decision came at a crowded TSBP meeting Feb. 11, 2014. "Another bureaucratic obstacle to medical practice has been stopped," said TMA General Counsel Donald "Rocky" Wilcox.